JP2022025114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022025114A5 JP2022025114A5 JP2021178501A JP2021178501A JP2022025114A5 JP 2022025114 A5 JP2022025114 A5 JP 2022025114A5 JP 2021178501 A JP2021178501 A JP 2021178501A JP 2021178501 A JP2021178501 A JP 2021178501A JP 2022025114 A5 JP2022025114 A5 JP 2022025114A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- region
- exendin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120024632A KR101665009B1 (ko) | 2012-03-09 | 2012-03-09 | 비알콜성 지방간 질환의 예방 또는 치료용 약학적 조성물 |
| KR10-2012-0024632 | 2012-03-09 | ||
| JP2019177304A JP2019214627A (ja) | 2012-03-09 | 2019-09-27 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019177304A Division JP2019214627A (ja) | 2012-03-09 | 2019-09-27 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022025114A JP2022025114A (ja) | 2022-02-09 |
| JP2022025114A5 true JP2022025114A5 (https=) | 2022-03-16 |
Family
ID=49117073
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560859A Pending JP2015510880A (ja) | 2012-03-09 | 2013-03-08 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
| JP2017173062A Pending JP2018009022A (ja) | 2012-03-09 | 2017-09-08 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
| JP2019177304A Pending JP2019214627A (ja) | 2012-03-09 | 2019-09-27 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
| JP2021178501A Pending JP2022025114A (ja) | 2012-03-09 | 2021-11-01 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560859A Pending JP2015510880A (ja) | 2012-03-09 | 2013-03-08 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
| JP2017173062A Pending JP2018009022A (ja) | 2012-03-09 | 2017-09-08 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
| JP2019177304A Pending JP2019214627A (ja) | 2012-03-09 | 2019-09-27 | 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20150056223A1 (https=) |
| EP (1) | EP2838549B1 (https=) |
| JP (4) | JP2015510880A (https=) |
| KR (1) | KR101665009B1 (https=) |
| CN (2) | CN104159597A (https=) |
| AR (1) | AR090287A1 (https=) |
| AU (1) | AU2013228152C1 (https=) |
| CA (1) | CA2864250C (https=) |
| DK (1) | DK2838549T3 (https=) |
| ES (1) | ES2900823T3 (https=) |
| HK (1) | HK1199220A1 (https=) |
| HU (1) | HUE057245T2 (https=) |
| IL (1) | IL234133B (https=) |
| IN (1) | IN2014DN06694A (https=) |
| MX (2) | MX2014010542A (https=) |
| MY (1) | MY167214A (https=) |
| NZ (1) | NZ628828A (https=) |
| PH (1) | PH12014501785A1 (https=) |
| PL (1) | PL2838549T3 (https=) |
| PT (1) | PT2838549T (https=) |
| RU (1) | RU2635966C2 (https=) |
| SG (1) | SG11201404733UA (https=) |
| TW (2) | TW201919688A (https=) |
| WO (1) | WO2013133667A1 (https=) |
| ZA (1) | ZA201405918B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20230404A1 (es) | 2011-06-17 | 2023-03-07 | Hanmi Science Co Ltd | Un conjugado que comprende oxintomodulina y un fragmento de inmunoglobulina, y uso del mismo |
| KR101968344B1 (ko) | 2012-07-25 | 2019-04-12 | 한미약품 주식회사 | 옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물 |
| PE20151421A1 (es) | 2012-11-06 | 2015-09-24 | Hanmi Pharm Ind Co Ltd | Formulacion liquida del conjugado de proteina que comprende la oxintomodulina y un fragmento de inmunoglobulina |
| EP3098235A4 (en) | 2014-01-20 | 2017-10-18 | Hanmi Pharm. Co., Ltd. | Long-acting insulin and use thereof |
| AR100639A1 (es) | 2014-05-29 | 2016-10-19 | Hanmi Pharm Ind Co Ltd | Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada |
| TWI684458B (zh) | 2014-05-30 | 2020-02-11 | 南韓商韓美藥品股份有限公司 | 包含胰島素及ｇｌｐ-１/昇糖素雙重促效劑之治療糖尿病之組成物 |
| TWI802396B (zh) * | 2014-09-16 | 2023-05-11 | 南韓商韓美藥品股份有限公司 | 長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途 |
| KR102418477B1 (ko) | 2014-12-30 | 2022-07-08 | 한미약품 주식회사 | 글루카곤 유도체 |
| EA201890058A1 (ru) * | 2015-06-30 | 2018-07-31 | Ханми Фарм. Ко., Лтд. | Производное глюкагона и композиция, содержащая длительно действующий конъюгат этого производного |
| UY36870A (es) | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | Análogos de insulina novedosos |
| WO2017052329A1 (en) * | 2015-09-24 | 2017-03-30 | Hanmi Pharm. Co., Ltd. | Protein complex by use of a specific site of an immunoglobulin fragment for linkage |
| KR20170065016A (ko) * | 2015-12-02 | 2017-06-12 | 한미약품 주식회사 | 지방산 유도체를 이용한 단백질 결합체 및 이의 제조방법 |
| RU2764197C1 (ru) | 2016-09-23 | 2022-01-14 | Ханми Фарм. Ко., Лтд. | Аналоги инсулина с пониженной аффинностью к рецептору инсулина и их применение |
| KR101906333B1 (ko) | 2016-12-07 | 2018-10-11 | 고려대학교 산학협력단 | 지방간의 진단 또는 치료를 위한 류신 지퍼 단백질의 용도 |
| KR101964743B1 (ko) | 2017-01-19 | 2019-08-14 | 울산대학교 산학협력단 | Gnpat을 유효성분으로 포함하는 비알콜성 지방간염 진단용 또는 치료 예후 예측용 바이오마커 조성물 |
| AR111341A1 (es) | 2017-03-23 | 2019-07-03 | Hanmi Pharm Ind Co Ltd | Un conjugado del análogo de insulina con afinidad reducida para el receptor de insulina y uso del mismo |
| CN109248323B (zh) * | 2017-07-14 | 2023-09-08 | 杭州先为达生物科技有限公司 | 酰化的glp-1衍生物 |
| EP3437651A1 (en) * | 2017-08-03 | 2019-02-06 | Université de Strasbourg | Peptides for treatment and prevention of nonalcoholic fatty liver disease |
| KR102174436B1 (ko) * | 2017-08-17 | 2020-11-04 | 주식회사 엘지화학 | 불용성 안료 화합물의 정성분석방법 |
| CN121591873A (zh) | 2018-07-19 | 2026-03-03 | D&D制药技术股份有限公司 | 包括多肽的药物组合物 |
| KR20200135618A (ko) | 2019-05-23 | 2020-12-03 | ㈜ 디앤디파마텍 | 폴리펩티드를 포함하는 비알코올성 지방간 질환의 예방 또는 치료용 약학 조성물 |
| KR102177304B1 (ko) | 2018-07-23 | 2020-11-10 | 제이투에이치바이오텍 (주) | 비알콜성 지방간염의 예방 또는 치료용 약학 조성물 |
| CN110151980B (zh) * | 2019-06-30 | 2022-12-09 | 中国药科大学 | Glp-1受体激动剂融合蛋白在制备预防或治疗高血脂药物中的应用 |
| KR102315866B1 (ko) * | 2020-03-24 | 2021-10-21 | 한국원자력의학원 | 섬유화 질환 복합 치료제 개발 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545618A (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
| US5424686A (en) | 1994-04-20 | 1995-06-13 | Philips Electronics North America Corporation | Negative-resistance-compensated microwave buffer |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| US8263084B2 (en) * | 2003-11-13 | 2012-09-11 | Hanmi Science Co., Ltd | Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| KR101135244B1 (ko) * | 2007-11-29 | 2012-04-24 | 한미사이언스 주식회사 | 인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물 |
| EP1689700A1 (en) * | 2003-11-25 | 2006-08-16 | Novo Nordisk A/S | Novel salicylic anilides |
| WO2007022518A2 (en) * | 2005-08-19 | 2007-02-22 | Amylin Pharmaceuticals, Inc. | New uses of glucoregulatory proteins |
| JP2008169195A (ja) | 2007-01-05 | 2008-07-24 | Hanmi Pharmaceutical Co Ltd | キャリア物質を用いたインスリン分泌ペプチド薬物結合体 |
| EP2123544B1 (en) * | 2007-03-06 | 2012-04-25 | Bridgestone Corporation | Rubber track |
| US8326420B2 (en) * | 2008-07-11 | 2012-12-04 | Medtronic, Inc. | Associating therapy adjustments with posture states using stability timers |
| UA101670C2 (ru) | 2008-07-23 | 2013-04-25 | Ханми Сайенс Ко., Лтд. | Полипептидный комплекс, содержащий непептидильный полимер, который имеет три функциональных конца |
| EP2248449A1 (en) * | 2009-05-08 | 2010-11-10 | Koninklijke Philips Electronics N.V. | Kitchen appliance |
| WO2011109787A1 (en) * | 2010-03-05 | 2011-09-09 | Conjuchem, Llc | Methods of administering insulinotropic peptides |
| KR101382593B1 (ko) * | 2010-07-21 | 2014-04-10 | 한미사이언스 주식회사 | 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물 |
-
2012
- 2012-03-09 KR KR1020120024632A patent/KR101665009B1/ko active Active
-
2013
- 2013-03-08 NZ NZ628828A patent/NZ628828A/en unknown
- 2013-03-08 CN CN201380013141.0A patent/CN104159597A/zh active Pending
- 2013-03-08 US US14/383,954 patent/US20150056223A1/en not_active Abandoned
- 2013-03-08 ES ES13757286T patent/ES2900823T3/es active Active
- 2013-03-08 RU RU2014133615A patent/RU2635966C2/ru active
- 2013-03-08 WO PCT/KR2013/001897 patent/WO2013133667A1/en not_active Ceased
- 2013-03-08 CN CN201811396462.4A patent/CN110075277A/zh active Pending
- 2013-03-08 EP EP13757286.3A patent/EP2838549B1/en active Active
- 2013-03-08 AR ARP130100760A patent/AR090287A1/es unknown
- 2013-03-08 JP JP2014560859A patent/JP2015510880A/ja active Pending
- 2013-03-08 MY MYPI2014002334A patent/MY167214A/en unknown
- 2013-03-08 PT PT137572863T patent/PT2838549T/pt unknown
- 2013-03-08 SG SG11201404733UA patent/SG11201404733UA/en unknown
- 2013-03-08 HK HK14112891.9A patent/HK1199220A1/xx unknown
- 2013-03-08 IN IN6694DEN2014 patent/IN2014DN06694A/en unknown
- 2013-03-08 AU AU2013228152A patent/AU2013228152C1/en active Active
- 2013-03-08 PL PL13757286T patent/PL2838549T3/pl unknown
- 2013-03-08 CA CA2864250A patent/CA2864250C/en active Active
- 2013-03-08 MX MX2014010542A patent/MX2014010542A/es unknown
- 2013-03-08 DK DK13757286.3T patent/DK2838549T3/da active
- 2013-03-08 TW TW107146976A patent/TW201919688A/zh unknown
- 2013-03-08 HU HUE13757286A patent/HUE057245T2/hu unknown
- 2013-03-08 TW TW102108194A patent/TWI658835B/zh active
-
2014
- 2014-08-07 PH PH12014501785A patent/PH12014501785A1/en unknown
- 2014-08-13 ZA ZA2014/05918A patent/ZA201405918B/en unknown
- 2014-08-14 IL IL234133A patent/IL234133B/en active IP Right Grant
- 2014-09-03 MX MX2020001697A patent/MX2020001697A/es unknown
-
2017
- 2017-09-08 JP JP2017173062A patent/JP2018009022A/ja active Pending
-
2019
- 2019-09-27 JP JP2019177304A patent/JP2019214627A/ja active Pending
-
2021
- 2021-11-01 JP JP2021178501A patent/JP2022025114A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022025114A5 (https=) | ||
| JP2015510880A5 (https=) | ||
| RU2014133615A (ru) | Фармацевтическая композиция для предупреждения или лечения неалкогольной жировой болезни печени | |
| KR102762409B1 (ko) | 지속형 glp-1/글루카곤 수용체 듀얼 아고니스트의 비알콜성 지방간질환에 대한 용도 | |
| AU2008330315B2 (en) | A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate | |
| JP2017529354A5 (https=) | ||
| RU2014108725A (ru) | Фармацевтическая композиция для лечения рака, содержащая конъюгат интерферона-альфа | |
| US9669105B2 (en) | Liquid formulations of long-acting interferon alpha conjugates | |
| CA2615122A1 (en) | Immunoconjugate formulations | |
| RU2013152335A (ru) | Композиция для лечения диабета, содержащая конъюгат инсулина длительного действия и конъюгат инсулинотропного пептида длительного действия | |
| RU2015138536A (ru) | Новый аналог инсулина и его применение | |
| JP2015503554A5 (https=) | ||
| JP2019524675A5 (https=) | ||
| HUE034398T2 (en) | Liquid formulations for long-acting g-csf conjugate | |
| RU2014115291A (ru) | Производные факторов свертывания крови vii и viiа, конъюгаты и комплексы, содержащие их, и их применение | |
| US20190127482A1 (en) | Conjugates of surrogate light chain constructs | |
| WO2023232140A1 (en) | Cancer treatment with a pd-1 or pd-l1 inhibitor and an antibody-drug conjugates targeting claudin 18.2 | |
| HK40005973A (en) | Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease | |
| NZ727871B2 (en) | Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist | |
| RU2021109760A (ru) | Терапевтическое использование глюкагона и его комбинации | |
| NZ764889B2 (en) | Composition for treating diabetes mellitus comprising insulin and a GLP-1/glucagon dual agonist | |
| JP2020093980A (ja) | 医薬 | |
| NZ752300A (en) | Use of a long acting glp-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease | |
| NZ739250B2 (en) | Glucagon derivative and a composition comprising a long acting conjugate of the same | |
| EA042870B1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени |